Current Therapy for Epilepsy J. Layne Moore, MD, MPH Professor Neurology Wright State University...
-
Upload
aron-swingler -
Category
Documents
-
view
213 -
download
0
Transcript of Current Therapy for Epilepsy J. Layne Moore, MD, MPH Professor Neurology Wright State University...
![Page 1: Current Therapy for Epilepsy J. Layne Moore, MD, MPH Professor Neurology Wright State University Boonshoft School of Medicine.](https://reader030.fdocuments.in/reader030/viewer/2022032702/56649cae5503460f94971d94/html5/thumbnails/1.jpg)
Current Therapy for EpilepsyJ. Layne Moore, MD, MPHProfessor NeurologyWright State University Boonshoft School of Medicine
![Page 2: Current Therapy for Epilepsy J. Layne Moore, MD, MPH Professor Neurology Wright State University Boonshoft School of Medicine.](https://reader030.fdocuments.in/reader030/viewer/2022032702/56649cae5503460f94971d94/html5/thumbnails/2.jpg)
Epilepsy
A disease known from antiquity
Initially thought to be from the attack of a spirit or demon The name epilepsy is derived from the Greek
word for “to attack” So a person does not “seizure” they are seized.
![Page 3: Current Therapy for Epilepsy J. Layne Moore, MD, MPH Professor Neurology Wright State University Boonshoft School of Medicine.](https://reader030.fdocuments.in/reader030/viewer/2022032702/56649cae5503460f94971d94/html5/thumbnails/3.jpg)
Rationale of Bloodletting
Bloodletting goes back 3000 years to the Egyptians.
To appreciate the rationale for bloodletting one must first understand the paradigm of disease 2300 years ago in the time of Hippocrates ( circa 460–370 BC).
Hippocrates believed that existence was represented by the four basic elements—earth, air, fire, and water—which in humans were related to the four basic humors: blood, phlegm, black bile, yellow bile. .
![Page 4: Current Therapy for Epilepsy J. Layne Moore, MD, MPH Professor Neurology Wright State University Boonshoft School of Medicine.](https://reader030.fdocuments.in/reader030/viewer/2022032702/56649cae5503460f94971d94/html5/thumbnails/4.jpg)
Humorism
![Page 5: Current Therapy for Epilepsy J. Layne Moore, MD, MPH Professor Neurology Wright State University Boonshoft School of Medicine.](https://reader030.fdocuments.in/reader030/viewer/2022032702/56649cae5503460f94971d94/html5/thumbnails/5.jpg)
![Page 6: Current Therapy for Epilepsy J. Layne Moore, MD, MPH Professor Neurology Wright State University Boonshoft School of Medicine.](https://reader030.fdocuments.in/reader030/viewer/2022032702/56649cae5503460f94971d94/html5/thumbnails/6.jpg)
![Page 7: Current Therapy for Epilepsy J. Layne Moore, MD, MPH Professor Neurology Wright State University Boonshoft School of Medicine.](https://reader030.fdocuments.in/reader030/viewer/2022032702/56649cae5503460f94971d94/html5/thumbnails/7.jpg)
Humorism
![Page 8: Current Therapy for Epilepsy J. Layne Moore, MD, MPH Professor Neurology Wright State University Boonshoft School of Medicine.](https://reader030.fdocuments.in/reader030/viewer/2022032702/56649cae5503460f94971d94/html5/thumbnails/8.jpg)
Ohio Hospital for epileptics at Gallipolis
Ohio
![Page 9: Current Therapy for Epilepsy J. Layne Moore, MD, MPH Professor Neurology Wright State University Boonshoft School of Medicine.](https://reader030.fdocuments.in/reader030/viewer/2022032702/56649cae5503460f94971d94/html5/thumbnails/9.jpg)
Ohio Hospital for epileptics at Gallipolis
Ohio
![Page 10: Current Therapy for Epilepsy J. Layne Moore, MD, MPH Professor Neurology Wright State University Boonshoft School of Medicine.](https://reader030.fdocuments.in/reader030/viewer/2022032702/56649cae5503460f94971d94/html5/thumbnails/10.jpg)
Ohio Hospital for epileptics at Gallipolis
Ohio
![Page 11: Current Therapy for Epilepsy J. Layne Moore, MD, MPH Professor Neurology Wright State University Boonshoft School of Medicine.](https://reader030.fdocuments.in/reader030/viewer/2022032702/56649cae5503460f94971d94/html5/thumbnails/11.jpg)
Ohio Hospital for epileptics at Gallipolis
Ohio
![Page 12: Current Therapy for Epilepsy J. Layne Moore, MD, MPH Professor Neurology Wright State University Boonshoft School of Medicine.](https://reader030.fdocuments.in/reader030/viewer/2022032702/56649cae5503460f94971d94/html5/thumbnails/12.jpg)
The commission consulted the foremost neurologists and alienists, at home and abroad, especially those experienced in the treatment of epilepsy, and submitted plans for the construction of 36 buildings for the segregation of epileptics in classified colonies, after the method of the Bielefeld Colony in Germany, as the best adapted for the welfare and treatment of those affected with epilepsy.
![Page 13: Current Therapy for Epilepsy J. Layne Moore, MD, MPH Professor Neurology Wright State University Boonshoft School of Medicine.](https://reader030.fdocuments.in/reader030/viewer/2022032702/56649cae5503460f94971d94/html5/thumbnails/13.jpg)
The Ohio Hospital for Epileptics
In 1892 the General Assembly passed an act changing the name of the institution from " The Asylum for Epileptics and Epileptic Insane " to " The Ohio Hospital for Epileptics."
![Page 14: Current Therapy for Epilepsy J. Layne Moore, MD, MPH Professor Neurology Wright State University Boonshoft School of Medicine.](https://reader030.fdocuments.in/reader030/viewer/2022032702/56649cae5503460f94971d94/html5/thumbnails/14.jpg)
http://www.asylumprojects.org/index.php?title=Gallipolis_Epileptic_Hospital
![Page 15: Current Therapy for Epilepsy J. Layne Moore, MD, MPH Professor Neurology Wright State University Boonshoft School of Medicine.](https://reader030.fdocuments.in/reader030/viewer/2022032702/56649cae5503460f94971d94/html5/thumbnails/15.jpg)
Hans Berger
![Page 16: Current Therapy for Epilepsy J. Layne Moore, MD, MPH Professor Neurology Wright State University Boonshoft School of Medicine.](https://reader030.fdocuments.in/reader030/viewer/2022032702/56649cae5503460f94971d94/html5/thumbnails/16.jpg)
Science to problem
![Page 17: Current Therapy for Epilepsy J. Layne Moore, MD, MPH Professor Neurology Wright State University Boonshoft School of Medicine.](https://reader030.fdocuments.in/reader030/viewer/2022032702/56649cae5503460f94971d94/html5/thumbnails/17.jpg)
Wilder Penfield
![Page 18: Current Therapy for Epilepsy J. Layne Moore, MD, MPH Professor Neurology Wright State University Boonshoft School of Medicine.](https://reader030.fdocuments.in/reader030/viewer/2022032702/56649cae5503460f94971d94/html5/thumbnails/18.jpg)
![Page 19: Current Therapy for Epilepsy J. Layne Moore, MD, MPH Professor Neurology Wright State University Boonshoft School of Medicine.](https://reader030.fdocuments.in/reader030/viewer/2022032702/56649cae5503460f94971d94/html5/thumbnails/19.jpg)
PB PHT CBZVPA
FBM
GBP
LTG
FOS
TPM
TGB
3rd G
ener
atio
n
“2nd Generation”
OCBZ
LVT
ZNS
Antiepileptic Drug (AED) Therapy
![Page 20: Current Therapy for Epilepsy J. Layne Moore, MD, MPH Professor Neurology Wright State University Boonshoft School of Medicine.](https://reader030.fdocuments.in/reader030/viewer/2022032702/56649cae5503460f94971d94/html5/thumbnails/20.jpg)
Newer AEDs
![Page 21: Current Therapy for Epilepsy J. Layne Moore, MD, MPH Professor Neurology Wright State University Boonshoft School of Medicine.](https://reader030.fdocuments.in/reader030/viewer/2022032702/56649cae5503460f94971d94/html5/thumbnails/21.jpg)
Rufinamide
developed in 2004 by Novartis and manufactured by Eisai. Approved for marketing 2008.
Approved as adjunct therapy for LGS
MOA uncertain perhaps sodium channels
![Page 22: Current Therapy for Epilepsy J. Layne Moore, MD, MPH Professor Neurology Wright State University Boonshoft School of Medicine.](https://reader030.fdocuments.in/reader030/viewer/2022032702/56649cae5503460f94971d94/html5/thumbnails/22.jpg)
Lacosamide
Approved in 2008
Voltage-gated sodium channels
UCB
Approved for adjunct therapy for partial onset
![Page 23: Current Therapy for Epilepsy J. Layne Moore, MD, MPH Professor Neurology Wright State University Boonshoft School of Medicine.](https://reader030.fdocuments.in/reader030/viewer/2022032702/56649cae5503460f94971d94/html5/thumbnails/23.jpg)
Ezogabine
A potassium channel Therefore unique
Effective in many animal models of epilepsy
Studies underway in neuropathic pain, tinnitus and migraine
TID dosing
![Page 24: Current Therapy for Epilepsy J. Layne Moore, MD, MPH Professor Neurology Wright State University Boonshoft School of Medicine.](https://reader030.fdocuments.in/reader030/viewer/2022032702/56649cae5503460f94971d94/html5/thumbnails/24.jpg)
Perampanel
acts as a selective noncompetitive antagonist of AMPA receptors.
Being studied in Parkinson’s disease
Half-life 105 hours
95% protein bound
![Page 25: Current Therapy for Epilepsy J. Layne Moore, MD, MPH Professor Neurology Wright State University Boonshoft School of Medicine.](https://reader030.fdocuments.in/reader030/viewer/2022032702/56649cae5503460f94971d94/html5/thumbnails/25.jpg)
Brivaracetam
Approval may be early 2015
it is around 10 times more potent for some models of epilepsy than Levetiracetam
![Page 26: Current Therapy for Epilepsy J. Layne Moore, MD, MPH Professor Neurology Wright State University Boonshoft School of Medicine.](https://reader030.fdocuments.in/reader030/viewer/2022032702/56649cae5503460f94971d94/html5/thumbnails/26.jpg)
VNS
Approved for partial epilepsy 1997
Approved for depression 2005
![Page 27: Current Therapy for Epilepsy J. Layne Moore, MD, MPH Professor Neurology Wright State University Boonshoft School of Medicine.](https://reader030.fdocuments.in/reader030/viewer/2022032702/56649cae5503460f94971d94/html5/thumbnails/27.jpg)
Responsive Neurostimulator Device
The RNS System utilizes a neurostimulator implanted in the skull with one or two leads implanted in the brain at focal points of seizures
![Page 28: Current Therapy for Epilepsy J. Layne Moore, MD, MPH Professor Neurology Wright State University Boonshoft School of Medicine.](https://reader030.fdocuments.in/reader030/viewer/2022032702/56649cae5503460f94971d94/html5/thumbnails/28.jpg)
Quality of Life
Side-effects
Mood
Anxiety
Stigma
Isolation
![Page 29: Current Therapy for Epilepsy J. Layne Moore, MD, MPH Professor Neurology Wright State University Boonshoft School of Medicine.](https://reader030.fdocuments.in/reader030/viewer/2022032702/56649cae5503460f94971d94/html5/thumbnails/29.jpg)
Genetics
Severe childhood epilepsies: Large international study pinpoints synapse genes with major roles
September 25, 2014
Children's Hospital of Philadelphia
An international research team has identified gene mutations causing severe, difficult-to-treat forms of childhood epilepsy. Many of the mutations disrupt functioning in the synapse, the junction at which nerve cells intercommunicate.
![Page 30: Current Therapy for Epilepsy J. Layne Moore, MD, MPH Professor Neurology Wright State University Boonshoft School of Medicine.](https://reader030.fdocuments.in/reader030/viewer/2022032702/56649cae5503460f94971d94/html5/thumbnails/30.jpg)
What’s New at WSU/PHP?
Looking at new medicines (Brivaracetam) for the treatment of in hospital non-convulsive status epilepticus
Assessment of stigma experienced by our epilepsy patients in clinic
![Page 31: Current Therapy for Epilepsy J. Layne Moore, MD, MPH Professor Neurology Wright State University Boonshoft School of Medicine.](https://reader030.fdocuments.in/reader030/viewer/2022032702/56649cae5503460f94971d94/html5/thumbnails/31.jpg)
What’s Next?
Science
Hope